TXNRD2

Chr 22AR

thioredoxin reductase 2

Also known as: GCCD5, SELZ, TR, TR-BETA, TR3, TRXR2, TXNR2

The protein encoded by TXNRD2 is a mitochondrial selenoenzyme that reduces thioredoxin and maintains mitochondrial redox homeostasis by scavenging reactive oxygen species. Mutations cause glucocorticoid deficiency 5, inherited in an autosomal recessive pattern. The gene shows very low constraint against loss-of-function variants (pLI near 0), which is consistent with recessive inheritance where heterozygous carriers are typically unaffected.

GeneReviewsOMIMResearchSummary from RefSeq, OMIM, UniProt
MultiplemechanismARLOEUF 0.991 OMIM phenotype
Clinical SummaryTXNRD2
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
219 unique Pathogenic / Likely Pathogenic· 456 VUS of 1093 total submissions
💊
Clinical Trials
1 active or recruiting trial — potential therapeutic options may be available
📖
GeneReview available — TXNRD2
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
0.99LOEUF
pLI 0.000
Z-score 1.60
OE 0.69 (0.490.99)
Tolerant

Typical tolerance to LoF variation

Missense Constraint
0.64Z-score
OE missense 0.90 (0.820.99)
296 obs / 328.5 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.69 (0.490.99)
00.351.4
Missense OE0.90 (0.820.99)
00.61.4
Synonymous OE1.07
01.21.6
LoF obs/exp: 21 / 30.5Missense obs/exp: 296 / 328.5Syn Z: -0.60
DN
0.6452th %ile
GOF
0.6736th %ile
LOF
0.3647th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

1093 submitted variants in ClinVar

Classification Summary

Pathogenic211
Likely Pathogenic8
VUS456
Likely Benign332
Benign55
Conflicting24
211
Pathogenic
8
Likely Pathogenic
456
VUS
332
Likely Benign
55
Benign
24
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
211
0
211
Likely Pathogenic
0
0
8
0
8
VUS
45
346
61
4
456
Likely Benign
0
9
145
178
332
Benign
0
1
53
1
55
Conflicting
24
Total453564781831,086

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

TXNRD2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold
Clinical Literature
Open Research Assistant →